Table 4 |
|||
|
Immunophenotype (n = 32) |
|||
|
Antibody |
Clonality |
+/Total number |
Percentage |
|
|
|||
|
CD45 |
PD7/26 |
11/32 |
34.4 |
|
CD20 |
L26 |
1/32 |
3.1 |
|
CD19 |
LE-CD19 |
1/32 |
3.1 |
|
CD79a |
JCB117 |
15/32 |
46.9 |
|
CD138 |
MI15 |
32/32 |
100 |
|
CD38 |
AT1 |
29/32 |
90.6 |
|
PC |
vs38c |
23/24 |
95.8 |
|
CD56 |
123C3 |
6/32 |
18.8 |
|
*CD117 |
- |
9/32 |
28.1 |
|
EMA |
E29 |
10/32 |
31.3 |
|
CD27 |
137B4 |
14/32 |
43.8 |
|
CD44v3 |
VEF-327v3 |
3/26 |
11.5 |
|
CD44v6 |
2F10 |
18/32 |
56.3 |
|
Bcl-2 |
124 |
31/32 |
96.9 |
|
CyclinD1 |
SP4 |
6/32 |
18.8 |
|
*Igκ |
- |
11/32 |
34.4 |
|
*Igλ |
- |
17/32 |
53.1 |
|
|
|||
|
* Polyclonal antibody |
|||
|
Zuo et al. Diagnostic Pathology 2011 6:123 doi:10.1186/1746-1596-6-123 |
|||
